Home / Student & Public Resources / USPTO BCP Meetings

USPTO Biotech/Chemical Partnership (BCP) Meetings

In This Section

The First Bicoastal Biotechnology, Chemical and Pharmaceutical (BCBCP) Partnership Meeting - Sep 17, 2014

Sep 17, 2014, 09:00 AM by AIPLA Admin

USPTO Logo

The United States Patent and Trademark Office

The First Bicoastal Biotechnology, Chemical and Pharmaceutical (BCBCP) Partnership Meeting

Wednesday, September 17, 2014

9:00am to 2:00pm (PDT)
San Jose State University, Engineering Building Conference Room E285/287

12:00pm to 5:00pm (EDT)
United States Patent and Trademark Office
USPTO Main Campus (Alexandria), Madison Auditorium

We are pleased to announce the USPTO’s first Bicoastal Biotechnology, Chemical and Pharmaceutical Customer Partnership (BCBCP) Meeting. This inaugural BCBCP expands our long-standing partnership in this industry sector to customers across the country. The next BCBCP Meeting will be held on September 17th and will be simultaneously available at locations on both the EAST (Alexandria, VA) and West (San Jose, CA) coasts.   During the BCBCP, participants will be able to interact with Office personnel in person on both coasts, or alternatively, via webcast. Please see below for registration information on how you can participate.
 

Date and Location:  The Partnership Meeting will be held on September 17th from 12:00pm – 5:00pm on the east coast and, at the same time, from 9:00am – 2:00pm on the west coast.


The Biotechnology, and Chemical and Pharmaceutical Customer Partnership was developed to create a collaborative forum for USPTO customers in this industry sector to share ideas, experiences, and insights with USPTO staff.  The BCBCP is intended to be informal in nature and will include participants from across the industry. 


Some of the topics to be discussed by USPTO staff and industry customers will include:

  • Markush claim practice
  • Patent application filing best practices
  • RCE practice
  • Overview of patent application initiatives
  • Panel discussion on U.S. Supreme Court decisions
    (e.g. Alice Corp., v. Cls Bank International. 134 S. Ct. 1537 (Supreme Court March 21, 2014); and Association for Molecular Pathology v. Myriad Genetics, Inc., 133 S. Ct. 2107, 186 L.Ed. 2d 124 (2013))

     

    Please check back and click here to view the final BCBCP Agenda once posted. The USPTO looks forward to hearing the individual views from its customers and does not intend to use this forum to seek or arrive at any consensus.  This customer partnership is formed with full recognition of the USPTO's responsibility under the Federal Advisory Committee Act (FACA), and accordingly, is not established as FACA compliant committee. 

9:00-9:10am (PDT)

12:00 – 12:10pm (EDT)

 

Welcoming Remarks (Introduction to the Inaugural BCBCP)

 

Margaret A. (Peggy) Focarino, Commissioner for Patents, USPTO (Alexandria)

9:10 – 9:30am (PDT)

12:10-12:30pm (EDT)

Opening Remarks

JohnCabeca, Director, Silicon Valley Office, USPTO (San Jose)

JerryLorengo, Director, TC1600, USPTO (Alexandria)

Dan Sullivan, Director, TC1600, USPTO (San Jose)

Wanda Walker, Director, TC1600, USPTO (Alexandria)

9:30 – 10:20am (PDT)

12:30-1:20pm (EDT)

Improper Markush

Joe Mallon, Partner,Knobbe, Martens, Olson & Bear, LLP (San Jose)

10:20 – 10:30am (PDT)

1:20-1:30pm (EDT)

Break

 

 

10:30-11:10am (PDT)

1:30 – 2:10pm (EDT)

OPAP Procedure and Tips

Kevin Little, OfficeofPatentApplicationProcessing (OPAP), USPTO (Alexandria)

11:10-11:40am (PDT)

2:10 – 2:40pm (EDT)

RCE Statistics and Reduction Initiatives

Brief Overview of AFCP 2.0 & QPIDS, and other Patent Application Initiatives)

Directors, TC1600andSilicon Valley Office, USPTO

11:40am –12:40pm (PDT)

2:40-3:40pm (EDT)

Discussion (Lunch West Coast)

Discussion (East Coast)

Directors,TC1600andSilicon Valley Office, USPTO

12:40 –12:50pm (PDT)

3:40-3:50pm (EDT)

 

Break


 

12:50-1:50pm (PDT)

3:50-4:50pm (EDT)

Myriad Guidance and CLS Decision

 

Panelists:

PaulNaik, Vice President, Intellectual Property, Genentech, Inc. (San Jose)

Suzannah K.Sundby, Partner, Canady & Lortz LLP (Alexandria)

Jeffery Tung, Patent Counsel, Isis Pharmaceuticals (San Jose)

June Cohan, Legal Advisory,OPLA, USPTO (Alexandria)

JerryLorengo, Director, TC 1600, USPTO (Alexandria)

Dan Sullivan, Director, TC1600, USPTO (San Jose)

 

1:50-2:00pm (PDT)

4:50-5:00pm (EDT)

Closing Remarks/Discussion

JohnCabeca, Director, Silicon Valley Office, USPTO

JerryLorengo, Director, TC1600, USPTO

Dan Sullivan, Director, TC1600, USPTO

Wanda Walker, Director, TC1600, USPTO